Wondfo Biotech announced that the company recently received seven chemiluminescence medical device registration certificates issued by the Guangdong Medical Products Administration, including a homocysteine assay kit, an insulin assay kit, glycated hemoglobin quality controls and calibrators, a laminin assay kit, a type III procollagen N-terminal peptide assay kit, and a type IV collagen assay kit. The newly approved products work in synergy with the company's existing offerings, continuously improving the product matrix for full-course liver disease testing, supplementing the need for islet function assessment, and supporting cardiovascular disease screening. The approval of these products has a positive impact on the company's development, but the impact on future revenue cannot yet be predicted.
Guangzhou Wondfo Biotech Co LtdObtained seven chemiluminescence medical device registration certificates, expanding product portfolio.
